Related Experiment Video

Updated: Jun 7, 2025

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

13.1K

[Tamoxifen, a high-potential molecule to treat all centronuclear myopathies]

Charlotte Gineste1, Jocelyn Laporte1

  • 1IGBMC - CNRS UMR 7104 - Inserm U 1258, Illkirch, France.

Medecine Sciences : M/S
|November 18, 2024
PubMed

Insights

Tamoxifen shows promise for treating centronuclear myopathies, rare muscle diseases. This study compares its effects across different forms of the condition in mouse models, offering hope for future therapies.

Area of Science:

  • Neurology
  • Genetics
  • Pharmacology

Background:

  • Centronuclear myopathies (CNMs) are rare genetic muscle disorders causing progressive weakness.
  • Key genes implicated include MTM1, DNM2, BIN1, and RYR1.
  • Currently, no specific treatments exist for CNMs.

Purpose of the Study:

  • To evaluate the therapeutic potential of tamoxifen in various centronuclear myopathy models.
  • To compare the efficacy of tamoxifen across different genetic forms of CNM.
  • To investigate tamoxifen's impact on muscle phenotypes in preclinical CNM models.

Main Methods:

  • Utilizing established mouse models representing different genetic subtypes of CNM.
  • Administering tamoxifen, a known pharmaceutical agent.
  • Assessing and comparing phenotypic improvements in muscle strength and function.

Main Results:

  • Tamoxifen demonstrated beneficial effects on muscle phenotypes in preclinical CNM models.
  • The study provides comparative data on tamoxifen's efficacy across various CNM forms.
  • Observed improvements suggest a potential therapeutic role for tamoxifen.

Conclusions:

  • Tamoxifen exhibits therapeutic potential for centronuclear myopathies.
  • Comparative analysis highlights tamoxifen's utility in diverse genetic CNM subtypes.
  • Further research may establish tamoxifen as a viable treatment option for CNM patients.

More Related Videos

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

18.7K
Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy10:30

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy

Published on: May 24, 2016

18.7K

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
655
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
466
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
222
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
2